Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerardo Botti

Showing results (101-110 of 396) with videos related to

Pageof 40
Sort By:
Tumori|December 24, 2013
Nuclear localization of cancer stem cell marker CD133 in triple-negative breast cancer: a case reportMonica Cantile, Francesca Collina, Massimiliano D'Aiuto, et al.
Journal of Cancer|November 22, 2017
Programmed Death Ligand 1 (PD-L1) Expression in Primary AngiosarcomaGerardo Botti, Giosuè Scognamiglio, Laura Marra, et al.
Journal of Breast Cancer|April 12, 2012
Aberrant Expression of Cancer Stem Cells Marker Prominin-1 in Low-Grade Tubulolobular Breast Carcinoma: A Correlative Study between qRT-PCR, Flow-Cytometric and Immunohistochemistry Analysis [corrected]Maurizio Di Bonito, Francesca Collina, Monica Cantile, et al.
Plos One|April 13, 2019
Correction: Nine-year distribution pattern of hepatitis C virus (HCV) genotypes in Southern ItalyArnolfo Petruzziello, Rocco Sabatino, Giovanna Loquercio, et al.
International Journal of Nanomedicine|August 9, 2020
Nano-Encapsulation of Coenzyme Q10 in Secondary and Tertiary Nano-Emulsions for Enhanced Cardioprotection and Hepatoprotection in Human Cardiomyocytes and Hepatocytes During Exposure to Anthracyclines and TrastuzumabVincenzo Quagliariello, Raffaele Vecchione, Alberta De Capua, et al.
Drugs|May 28, 2016
Cancer Treatment with Anti-PD-1/PD-L1 Agents: Is PD-L1 Expression a Biomarker for Patient Selection?Lucia Festino, Gerardo Botti, Paul Lorigan, et al.
Current Drug Targets|June 14, 2014
Detection of predictive markers for therapeutic stratification of salivary glands tumorsMonica Cantile, Simona Losito, Francesco Longo, et al.
Journal of Breast Cancer|July 19, 2012
Overexpression of Cell Cycle Progression Inhibitor Geminin is Associated with Tumor Stem-Like Phenotype of Triple-Negative Breast CancerMaurizio Di Bonito, Monica Cantile, Francesca Collina, et al.
International Journal of Molecular Sciences|September 28, 2021
The Role of lncRNAs in Rare Tumors with a Focus on HOX Transcript Antisense RNA (<i>HOTAIR</i>)Giuseppina Liguori, Margherita Cerrone, Annarosaria De Chiara, et al.
Oncotarget|August 6, 2016
Differential expression of cyclooxygenase-2 in metastatic melanoma affects progression free survivalElisabetta Panza, Paola De Cicco, Giuseppe Ercolano, et al.
Pageof 40

Showing results (101-110 of 396) with videos related to

Sort By:
Pageof 40
Tumori|December 24, 2013
Nuclear localization of cancer stem cell marker CD133 in triple-negative breast cancer: a case reportMonica Cantile, Francesca Collina, Massimiliano D'Aiuto, et al.
Journal of Cancer|November 22, 2017
Programmed Death Ligand 1 (PD-L1) Expression in Primary AngiosarcomaGerardo Botti, Giosuè Scognamiglio, Laura Marra, et al.
Journal of Breast Cancer|April 12, 2012
Aberrant Expression of Cancer Stem Cells Marker Prominin-1 in Low-Grade Tubulolobular Breast Carcinoma: A Correlative Study between qRT-PCR, Flow-Cytometric and Immunohistochemistry Analysis [corrected]Maurizio Di Bonito, Francesca Collina, Monica Cantile, et al.
Plos One|April 13, 2019
Correction: Nine-year distribution pattern of hepatitis C virus (HCV) genotypes in Southern ItalyArnolfo Petruzziello, Rocco Sabatino, Giovanna Loquercio, et al.
International Journal of Nanomedicine|August 9, 2020
Nano-Encapsulation of Coenzyme Q10 in Secondary and Tertiary Nano-Emulsions for Enhanced Cardioprotection and Hepatoprotection in Human Cardiomyocytes and Hepatocytes During Exposure to Anthracyclines and TrastuzumabVincenzo Quagliariello, Raffaele Vecchione, Alberta De Capua, et al.
Drugs|May 28, 2016
Cancer Treatment with Anti-PD-1/PD-L1 Agents: Is PD-L1 Expression a Biomarker for Patient Selection?Lucia Festino, Gerardo Botti, Paul Lorigan, et al.
Current Drug Targets|June 14, 2014
Detection of predictive markers for therapeutic stratification of salivary glands tumorsMonica Cantile, Simona Losito, Francesco Longo, et al.
Journal of Breast Cancer|July 19, 2012
Overexpression of Cell Cycle Progression Inhibitor Geminin is Associated with Tumor Stem-Like Phenotype of Triple-Negative Breast CancerMaurizio Di Bonito, Monica Cantile, Francesca Collina, et al.
International Journal of Molecular Sciences|September 28, 2021
The Role of lncRNAs in Rare Tumors with a Focus on HOX Transcript Antisense RNA (<i>HOTAIR</i>)Giuseppina Liguori, Margherita Cerrone, Annarosaria De Chiara, et al.
Oncotarget|August 6, 2016
Differential expression of cyclooxygenase-2 in metastatic melanoma affects progression free survivalElisabetta Panza, Paola De Cicco, Giuseppe Ercolano, et al.
Pageof 40